down arrow

Kidswell Bio Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3386460004
  • TKS: 4584
JPY
166.00
-1 (-0.6%)

Sep 25

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,269.51
1,571.11
1,742.60
1,555.59
1,720.63
2,045.75
1,286.39
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,269.51
1,571.11
1,742.60
1,555.59
1,720.63
2,045.75
1,286.39
Raw Material Cost
838.12
1,153.70
1,405.37
1,160.06
1,123.41
1,436.25
748.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
23.06
21.08
10.19
8.23
9.55
10.11
9.67
Selling and Distribution Expenses
182.22
191.02
185.85
188.56
200.49
217.44
212.98
Other Expenses
0.96
42.79
27.25
16.80
20.25
21.62
19.10
Total Expenditure (Excl Depreciation)
1,053.00
1,793.69
1,873.86
1,524.90
1,535.98
1,879.96
1,161.78
Operating Profit (PBDIT) excl Other Income
216.5
-222.60000000000002
-131.3
30.7
184.7
165.79999999999998
124.60000000000001
Other Income
10.86
2.63
-70.14
-121.40
0.52
77.04
-8.15
Operating Profit (PBDIT)
227.40
-219.90
-201.34
-90.65
185.23
243.28
116.47
Interest
23.06
21.08
10.19
8.23
9.55
10.11
9.67
Exceptional Items
32.73
-37.57
0.00
10.61
0.00
-25.75
0.00
Gross Profit (PBDT)
431.39
417.41
337.24
395.53
597.23
609.50
538.29
Depreciation
0.03
0.06
0.06
0.06
0.06
0.45
0.00
Profit Before Tax
237.03
-278.62
-211.59
-88.34
175.62
206.96
106.80
Tax
39.13
-7.42
-8.21
8.20
18.49
40.33
52.78
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
197.90
-271.19
-203.38
-96.54
157.13
166.63
54.02
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
197.90
-271.19
-203.38
-96.54
157.13
166.63
54.02
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
197.90
-271.19
-203.38
-96.54
157.13
166.63
54.02
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,837.45
1,653.92
1,926.07
2,186.18
2,048.00
1,410.98
1,052.23
Earnings per share (EPS)
3.9
-5.46
-4.1
-1.95
3.26
3.8
1.33
Diluted Earnings per share
3.9
-5.46
-4.1
-1.95
3.26
3.8
1.33
Operating Profit Margin (Excl OI)
17.05%
-14.17%
-7.53%
1.97%
10.73%
8.1%
9.69%
Gross Profit Margin
18.67%
-17.73%
-12.14%
-5.67%
10.21%
10.14%
8.3%
PAT Margin
15.59%
-17.26%
-11.67%
-6.21%
9.13%
8.15%
4.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -19.20% vs -9.84% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 172.97% vs -33.33% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 197.30% vs -69.59% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 9.48% vs 106.86% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Kidswell Bio Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
1,269.51
75.84
1,193.67
1,573.93%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,269.51
75.84
1,193.67
1,573.93%
Raw Material Cost
838.12
31.11
807.01
2,594.05%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
23.06
5.80
17.26
297.59%
Selling and Distribution Expenses
182.22
246.31
-64.09
-26.02%
Other Expenses
0.96
-0.58
1.54
265.52%
Total Expenditure (Excl Depreciation)
1,053.00
277.42
775.58
279.57%
Operating Profit (PBDIT) excl Other Income
216.51
-201.57
418.08
207.41%
Other Income
10.86
-2.44
13.30
545.08%
Operating Profit (PBDIT)
227.40
-197.85
425.25
214.94%
Interest
23.06
5.80
17.26
297.59%
Exceptional Items
32.73
0.00
32.73
Gross Profit (PBDT)
431.39
44.73
386.66
864.43%
Depreciation
0.03
6.16
-6.13
-99.51%
Profit Before Tax
237.03
-209.81
446.84
212.97%
Tax
39.13
0.64
38.49
6,014.06%
Provisions and contingencies
0
0
0.00
Profit After Tax
197.90
-210.44
408.34
194.04%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
197.90
-210.44
408.34
194.04%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
197.90
-210.44
408.34
194.04%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,837.45
2,622.18
-784.73
-29.93%
Earnings per share (EPS)
3.90
-20.90
24.80
118.66%
Diluted Earnings per share
3.90
-20.90
24.80
118.66%
Operating Profit Margin (Excl OI)
17.05%
-265.78%
0.00
282.83%
Gross Profit Margin
18.67%
-268.52%
0.00
287.19%
PAT Margin
15.59%
-277.47%
0.00
293.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 126.95 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -19.20% vs -9.84% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -26.22% vs 256.23% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 19.79 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 172.97% vs -33.33% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 25.97% vs 188.91% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 21.65 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 197.30% vs -69.59% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 17.22% vs 216.38% in Jun 2025

Quarterly - Interest
Interest 2.31 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 9.48% vs 106.86% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 140.63% vs -15.04% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.05%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading